ES2076399T3 - Estimulacion inmunologica del efecto somatogenico de la somatotropina con un anticuerpo. - Google Patents

Estimulacion inmunologica del efecto somatogenico de la somatotropina con un anticuerpo.

Info

Publication number
ES2076399T3
ES2076399T3 ES91106423T ES91106423T ES2076399T3 ES 2076399 T3 ES2076399 T3 ES 2076399T3 ES 91106423 T ES91106423 T ES 91106423T ES 91106423 T ES91106423 T ES 91106423T ES 2076399 T3 ES2076399 T3 ES 2076399T3
Authority
ES
Spain
Prior art keywords
antibody
somatogenic
somatotropin
effect
immunological stimulation
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES91106423T
Other languages
English (en)
Inventor
Bosco Shang Wang
Araceli L Lumanglas
Ian C Hart
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Wyeth Holdings LLC
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Application granted granted Critical
Publication of ES2076399T3 publication Critical patent/ES2076399T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/26—Immunoglobulins [IG], e.g. monoclonal or polyclonal antibodies against material from animals or humans against hormones ; against hormone releasing or inhibiting factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Endocrinology (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Feed For Specific Animals (AREA)
  • Fodder In General (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

LA INVENCION SE REFIERE A ANTICUERPOS, SOBRE TODO A ANTICUERPOS MONOCLONALES, DE SOMATOTROPINA PORCINA (PST). CUANDO ESTOS ANTICUERPOS SE SUMINISTRAN JUNTO CON LA PST, EL CRECIMIENTO DE VERTEBRADOS ES MAYOR QUE EL ALCANZADO CUANDO SE ADMINISTRA LA PST POR SI SOLA. LA INVENCION TAMBIEN SE REFIERE A UN AUMENTO EN EL CRECIMIENTO DE VERTEBRADOS QUE PERDURA LARGOS PERIODOS DE TIEMPO CUANDO UN ANTICUERPO A UNA SOMATOTROPINA SE ADMINISTRA JUNTO CON DICHA SOMATOTROPINA.
ES91106423T 1990-05-15 1991-04-22 Estimulacion inmunologica del efecto somatogenico de la somatotropina con un anticuerpo. Expired - Lifetime ES2076399T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/521,695 US6165465A (en) 1990-05-15 1990-05-15 Immunologic enhancement of the somatogenic effect of somatotropin with an antibody

Publications (1)

Publication Number Publication Date
ES2076399T3 true ES2076399T3 (es) 1995-11-01

Family

ID=24077752

Family Applications (1)

Application Number Title Priority Date Filing Date
ES91106423T Expired - Lifetime ES2076399T3 (es) 1990-05-15 1991-04-22 Estimulacion inmunologica del efecto somatogenico de la somatotropina con un anticuerpo.

Country Status (18)

Country Link
US (1) US6165465A (es)
EP (1) EP0458072B1 (es)
JP (1) JPH04228091A (es)
KR (1) KR910019639A (es)
AT (1) ATE127849T1 (es)
AU (1) AU648303B2 (es)
CA (1) CA2042437A1 (es)
DE (1) DE69112904T2 (es)
DK (1) DK0458072T3 (es)
ES (1) ES2076399T3 (es)
FI (1) FI98828C (es)
GR (1) GR3017412T3 (es)
IE (1) IE69575B1 (es)
IL (1) IL97933A (es)
NO (1) NO911877L (es)
NZ (1) NZ238070A (es)
PT (1) PT97650B (es)
ZA (1) ZA913646B (es)

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1341012C (en) * 1982-09-27 2000-06-06 Biogen, Inc. Dna sequences, recombinant dna molecules and processes for producing swine growth hormone-like polypeptides
AU2092983A (en) * 1982-11-08 1984-05-17 Genentech Inc. Porcine growth hormone produced by recombinant dna technology
US4925922A (en) * 1983-02-22 1990-05-15 Xoma Corporation Potentiation of cytotoxic conjugates
CA1259923A (en) * 1983-08-17 1989-09-26 Roger Aston Physiologically active compositions
US4599229A (en) * 1985-09-09 1986-07-08 International Minerals & Chemical Corp. Method of promoting animal growth using antibodies against somatostatin
US4764475A (en) * 1986-12-01 1988-08-16 The University Of British Columbia Pancreas dependant immunoassay for determining subpopulations of monoclonal antibodies to somatostatin.
GB8707398D0 (en) * 1987-03-27 1987-04-29 Coopers Animal Health Biologically active molecules
FI900075L (fi) * 1987-07-06 1990-01-05 Peptide Technology Ltd Medvaexthormon bindande peptid.
GB8718937D0 (en) * 1987-08-11 1987-09-16 Coopers Animal Health Biologically active molecules
NZ225760A (en) * 1987-08-14 1991-02-26 Bio Technology General Corp Expression plasmids containing the deo promoter and bacterial hosts containing these plasmids
US4837202A (en) * 1987-09-14 1989-06-06 Pitman-Moore, Inc. Method for stimulating the immune system
DK8189A (da) * 1988-01-12 1989-07-13 Bunge Australia Antigen-antistof-konjugater, deres fremstilling og anvendelse

Also Published As

Publication number Publication date
GR3017412T3 (en) 1995-12-31
DE69112904D1 (de) 1995-10-19
EP0458072B1 (en) 1995-09-13
ATE127849T1 (de) 1995-09-15
FI912341L (fi) 1991-11-16
KR910019639A (ko) 1991-12-19
PT97650B (pt) 1998-08-31
ZA913646B (en) 1992-02-26
JPH04228091A (ja) 1992-08-18
CA2042437A1 (en) 1991-11-16
AU7606491A (en) 1991-11-21
EP0458072A1 (en) 1991-11-27
FI912341A0 (fi) 1991-05-14
AU648303B2 (en) 1994-04-21
NO911877D0 (no) 1991-05-14
NZ238070A (en) 1993-08-26
DK0458072T3 (da) 1995-11-13
US6165465A (en) 2000-12-26
FI98828C (fi) 1997-08-25
IE911198A1 (en) 1991-11-20
IL97933A (en) 1995-08-31
IE69575B1 (en) 1996-10-02
PT97650A (pt) 1992-03-31
NO911877L (no) 1991-11-18
DE69112904T2 (de) 1996-05-15
FI98828B (fi) 1997-05-15
IL97933A0 (en) 1992-06-21

Similar Documents

Publication Publication Date Title
EA199700272A1 (ru) Вакцины, содержащие сапонин и стерин
ES2084827T3 (es) Composiciones de vacuna mejoradas.
DK602989A (da) Saponinadjuvans
PT752876E (pt) Anticorpos monoclonicos que se conectam com o percursor antigeneo de rejeicao de tumores mage-1, mage-1 recombinante, e peptidos imunogenicos derivados de mage-1
ES2120073T3 (es) Agente inductor de tolerancia inmunologica.
ES2059413T3 (es) Anticuerpos monoclonales contra antigenos asociados a melanoma, progenies celulares hibridas que producen estos anticuerpos, y su empleo correspondiente.
DK0466037T3 (da) Fremgangsmåde til fremstilling af et gærglucan
BR9809656A (pt) Composição imunopotencializante
AR023535A1 (es) Nuevas composiciones.
ES2194836T3 (es) Peptidos para su uso en vacunacion e induccion de anticuerpos neutralizantes contra el virus de la inmunodeficiencia humana.
SE8601644D0 (sv) Antikroppspreparation riktad mot vissa determinanter i human c3 samt dess anvendning och framstellning
DE60315827D1 (de) Verbesserte polysaccharid- und glykokonjugat-vakzine
ES2076399T3 (es) Estimulacion inmunologica del efecto somatogenico de la somatotropina con un anticuerpo.
ES2099143T3 (es) Anticuerpos monoclonales contra el alergeno de acaros y su uso.
ES2124701T3 (es) Composiciones de vacunas.
ES2097207T3 (es) Receptor de poli-ig de sintesis, complejos receptor-anticuerpo, produccion y aplicacion de los mismos.
AR047819A1 (es) Un anticuerpo monoclonal anti-tenascina humana
EP0585364A4 (en) THE ANTIQUE CTAA 81AV78 RECOGNIZED BY THE MONOCLONAL HUMAN ANTIBODY 81AV78.
MX9102647A (es) Nueva proteina capaz de inducir una respuesta inmunoprotectora contra la infeccion causada por toxoplasma gondii y para clonar y expresar un gen que codifica a la proteina.
ES2055066T3 (es) Anticuerpos monoclonales que reconocen el extremo n del gamma polipeptido natriuretico atrial, hibridomas que los producen y su preparacion y aplicacion.
SE8404090D0 (sv) Raffinerat detoxifierat endotoxin
IT1249051B (it) Immunotossina da anticorpi monoclonali anti-cd5
SE8901264L (sv) Uttryck av laxtillvaexthormon i metylotropisk jaest av slaektet pichia
KR930703006A (ko) 백신, 특히 돼지의 흉막폐염 백신의 면역강화
TR199902290A2 (xx) Cu+2 aracılığı ile oluşan ve steroid hormon, protein ve toksik olmayan polianyonik polielektrolit içeren immünojenik biopolimer sistemleri.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 458072

Country of ref document: ES